PROCEPT BioRobotics Corp (PRCT)
68.69
-0.50
(-0.72%)
USD |
NASDAQ |
May 16, 15:20
PROCEPT BioRobotics Cash from Operations (TTM): -104.36M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -104.36M |
December 31, 2023 | -108.00M |
September 30, 2023 | -108.38M |
June 30, 2023 | -109.29M |
March 31, 2023 | -98.08M |
Date | Value |
---|---|
December 31, 2022 | -80.38M |
September 30, 2022 | -71.68M |
June 30, 2022 | -64.58M |
March 31, 2022 | -60.37M |
December 31, 2021 | -57.33M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-109.29M
Minimum
Jun 2023
-57.33M
Maximum
Dec 2021
-86.25M
Average
-89.23M
Median
Cash from Operations (TTM) Benchmarks
Globus Medical Inc | 242.57M |
Glaukos Corp | -60.86M |
Integra Lifesciences Holdings Corp | 129.56M |
Intuitive Surgical Inc | 1.708B |
Masimo Corp | 139.50M |